Shanghai Pioneer Holding (HKSE:01345) YoY EBITDA Growth : -38.76% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Shanghai Pioneer Holding's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -38.76%.

Shanghai Pioneer Holding's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.08.

Shanghai Pioneer Holding YoY EBITDA Growth Historical Data

The historical data trend for Shanghai Pioneer Holding's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding YoY EBITDA Growth Chart

Shanghai Pioneer Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

38.68

-29.93

112.62

32.88

-35.74

Shanghai Pioneer Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															197.06	49.49	27.72	-42.57	-38.76

Shanghai Pioneer Holding YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Shanghai Pioneer Holding's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.187	-	0.291)	/	\| 0.291 \|
=	-35.74 %

Shanghai Pioneer Holding's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.079	-	0.129)	/	\| 0.129 \|
=	-38.76 %

Shanghai Pioneer Holding YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pioneer Holding (HKSE:01345) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331

Website

http://www.pioneer-pharma.com

Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.

Executives

Bank Of Communications Trustee Limited	2301 Trustee
Pioneer Pharma (bvi) Co.,ltd	2101 Beneficial owner
Tian Tian Limited	2201 Interest of corporation controlled by you
Li Xinzhou	2202 Interest of your spouse
Wu Qian	2201 Interest of corporation controlled by you

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines